Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ofloxacin”

202 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 202 results

Large-scale testing (Phase 3)UnknownNCT00215007
What this trial is testing

Trial of Levofloxacin as Prophylaxis After Allogeneic Stem Cell Transplantation (SCT)

Who this might be right for
MalignancyAllogeneic Stem Cell Transplantation
Charite University, Berlin, Germany
Large-scale testing (Phase 3)Study completedNCT00277511
What this trial is testing

Levofloxacin, Chronic Bacterial Prostatitis

Who this might be right for
Prostatitis
Sanofi 120
Large-scale testing (Phase 3)Study completedNCT01529476
What this trial is testing

Study to Evaluate the Efficacy and Safety of Oral Administration With Nemonoxacin and Levofloxacin in Patients With CAP

Who this might be right for
Pneumonia
TaiGen Biotechnology Co., Ltd. 540
Large-scale testing (Phase 3)Study completedNCT00257140
What this trial is testing

The Safety and Effectiveness of Levofloxacin Compared With Cefaclor in the Treatment of Adults With Chronic Bronchitis Experiencing Rapid Onset of Worsening of Symptoms Caused by Bacteria

Who this might be right for
BronchitisBronchitis, Chronic
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 367
Large-scale testing (Phase 3)Ended earlyNCT00906048
What this trial is testing

LEVOS - Levofloxacin and Rifampicin Therapy in the Treatment of OsteoArticular Prothethic Infection

Who this might be right for
Infection
Sanofi 10
Testing effectiveness (Phase 2)Study completedNCT06616922
What this trial is testing

Assessment of the Effects and Tolerability of RD03/2016 for the Treatment of Bacterial Conjunctivitis in Adults

Who this might be right for
Conjunctivitis, Bacterial
NTC srl 252
Not applicableStudy completedNCT00279864
What this trial is testing

The Utility of Levofloxacin-Rifampin in the Therapy of Prosthetic Joint Infection

Who this might be right for
Staphylococcal InfectionStaphylococcus Aureus Prosthetic Joint Infection
Mayo Clinic 15
Early research (Phase 1)UnknownNCT03397680
What this trial is testing

Effectiveness of Once-daily Dose Regimen of 7-day and 14-day High Dose Rabeprazole-levofloxacin Based Quadruple Therapy for H. Pylori Eradication in Thai Patients With Non-ulcer Dyspepsia

Who this might be right for
Helicobacter Pylori Infection
Thammasat University 100
Not applicableLooking for participantsNCT04496024
What this trial is testing

Ofloxacin Concentration-toxicity Relationship in the Elderly

Who this might be right for
OfloxacinBone and Joint InfectionTherapeutic Drug Monitoring+1 more
Centre Hospitalier Universitaire, Amiens 110
Testing effectiveness (Phase 2)Study completedNCT00434291
What this trial is testing

Safety and Efficacy Comparison of TG-873870(Nemonoxacin) to Levofloxacin in Community-Acquired Pneumonia

Who this might be right for
Community-Acquired Pneumonia
TaiGen Biotechnology Co., Ltd. 264
Early research (Phase 1)Study completedNCT03519516
What this trial is testing

Safety and Tolerability of the PRO-174 Versus Sophixín Ofteno®, on the Ocular Surface of Healthy Subjects

Who this might be right for
ConjunctivitisConjunctivitis, Bacterial
Laboratorios Sophia S.A de C.V. 30
Large-scale testing (Phase 3)Study completedNCT03594149
What this trial is testing

Efficiency of Antibacterial Prophylaxis in Azacitidine Treated Patients

Who this might be right for
Myelodysplastic SyndromesAcute Myeloid Leukemia
Centre Henri Becquerel 60
Testing effectiveness (Phase 2)Study completedNCT03698682
What this trial is testing

Short Compared With Standard Duration of Antibiotic Treatment for AECOPD

Who this might be right for
Chronic Obstructive Pulmonary Disease
University of Monastir 310
Post-approval studies (Phase 4)UnknownNCT03391440
What this trial is testing

A Trial to Assess the Efficacy and Safety of Morinidazole in Women With Pelvic Inflammatory Disease

Who this might be right for
Pelvic Inflammatory Disease
Jiangsu Hansoh Pharmaceutical Co., Ltd. 469
Post-approval studies (Phase 4)Study completedNCT01032655
What this trial is testing

The Efficacy of Susceptibility Test -Driven Sequential Therapy as the Third Line Therapy for Refractory Helicobacter Pylori Infection

Who this might be right for
Helicobacter Pylori Infection
National Taiwan University Hospital 134
Post-approval studies (Phase 4)Study completedNCT00816140
What this trial is testing

Levofloxacin Versus Clarithromycin Triple Therapy in First-Line Treatment for Helicobacter Pylori Eradication

Who this might be right for
Helicobacter Infections
National Taiwan University Hospital 432
Testing effectiveness (Phase 2)Study completedNCT01096849
What this trial is testing

Plazomicin Compared With Levofloxacin for the Treatment of Complicated Urinary Tract Infection (cUTI) and Acute Pyelonephritis (AP)

Who this might be right for
Complicated Urinary Tract InfectionAcute Pyelonephritis
Achaogen, Inc. 145
Large-scale testing (Phase 3)Study completedNCT00079885
What this trial is testing

Study Evaluating Tigecycline vs Levofloxacin in Hospitalized With Community-Acquired Pneumonia

Who this might be right for
Community Acquired PneumoniaBacterial PneumoniaCross Infection
Wyeth is now a wholly owned subsidiary of Pfizer 430
Not applicableStudy completedNCT02169141
What this trial is testing

Pharmacokinetics of Levofloxacin and Capreomycin in Multidrug-Resistant Tuberculosis Patients

Who this might be right for
Tuberculosis
University Medical Center Groningen 20
Large-scale testing (Phase 3)Study completedNCT00236652
What this trial is testing

A Study Evaluating the Safety and Efficacy of Treating Sinus Infection With Levofloxacin 750 mg for 5 Days.

Who this might be right for
Maxillary Sinusitis
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 18
Load More Results